Do COVID-19 Related Prostate Cancer Treatment Delays Impact Oncological Outcomes?
DELAYS in nonemergent surgery for prostate cancer (PC), as a result of the coronavirus 2019 (COVID-19) pandemic, have been shown to not adversely affect oncological outcomes according to results from a large European cohort.